about
Potential role for mammalian target of rapamycin inhibitors as first-line therapy in hormone receptor-positive advanced breast cancerAntitumor activity of SA12, a novel peptide, on SKBr-3 breast cancer cells via the mitochondrial apoptosis pathwayDirect Melanoma Cell Contact Induces Stromal Cell Autocrine Prostaglandin E2-EP4 Receptor Signaling That Drives Tumor Growth, Angiogenesis, and Metastasis.Ovarian cancer and DNA repair: DNA ligase IV as a potential key.Mechanical stress promotes cisplatin-induced hepatocellular carcinoma cell death.Peptide SA12 inhibits proliferation of breast cancer cell lines MCF-7 and MDA-MB-231 through G0/G1 phase cell cycle arrest.
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Targeted therapies in breast cancer
@ast
Targeted therapies in breast cancer
@en
Targeted therapies in breast cancer
@nl
type
label
Targeted therapies in breast cancer
@ast
Targeted therapies in breast cancer
@en
Targeted therapies in breast cancer
@nl
prefLabel
Targeted therapies in breast cancer
@ast
Targeted therapies in breast cancer
@en
Targeted therapies in breast cancer
@nl
P356
P1433
P1476
Targeted therapies in breast cancer
@en
P2093
P304
P356
10.4414/SMW.2012.13550
P407
P577
2012-04-27T00:00:00Z